Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. [electronic resource]
Producer: 20090608Description: 636-47 p. digitalISSN:- 1535-7163
- Animals
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- administration & dosage
- Biomarkers, Tumor -- genetics
- Dacarbazine -- administration & dosage
- Drug Delivery Systems -- methods
- Drug Synergism
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Imidazoles -- administration & dosage
- Melanoma -- drug therapy
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Models, Biological
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- administration & dosage
- Quinoxalines -- administration & dosage
- Skin Neoplasms -- drug therapy
- Sorafenib
- Substrate Specificity
- Temozolomide
- Treatment Outcome
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.